DCs are one of the major APCs, with a vital role in the communication between innate and adaptive immunity.[117] Modulation of the DC antigens to cross‐presentation CD8+ T cells is critically needed for effective anti‐tumor response and considered to be an attractive TME target. Here, CD8A is linked to neoplasm.